I don't think it will be clear that Pfizer is "more effective" until we see the two-dose J&J study come in. > J&J doesn't really need to be scaled up because t

I don't think it will be clear that Pfizer is "more effective" until we see the two-dose J&J study come in. > J&J doesn't really need to be scaled up because they alone have the ability to produce so much of it. I'd bet 100 dollars that J&J ships less than a billion doses before July. Are you willing to take the other side of the bet? If I'm right, that means that they could have "used help" even though they "have the ability to produce so much of it." Edit: Before you take my bet, which I'm happy if you do, you may want to read this: https://www.nytimes.com/2021/01/13/health/covid-vaccine-johnson-johnson.html#:~:text=In%20the%20company's%20%241%20billion,by%20the%20end%20of%20June https://www.nytimes.com/2021/01/13/health/covid-vaccine-john....